Caroline Pirritt
-
- Growth Hormone and Insulin-like Growth Factors 4
-
- Cancer, Hypoxia, and Metabolism 3
-
- Metabolism, Diabetes, and Cancer 2
- PI3K/AKT/mTOR signaling in cancer 2
-
- Cancer-related Molecular Pathways 1
- Cancer Treatment and Pharmacology 1
- Lung Cancer Research Studies 1
-
- Lung Cancer Treatments and Mutations 1
Caroline Pirritt
5 papers receiving 356 citations
Peers
Comparison fields: 5 of 61
- Endocrinology, Diabetes and Metabolism 180
- Cancer Research 92
- Molecular Biology 248
- Oncology 87
- Genetics 22
Countries citing papers authored by Caroline Pirritt
This map shows the geographic impact of Caroline Pirritt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caroline Pirritt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caroline Pirritt more than expected).
Fields of papers citing papers by Caroline Pirritt
This network shows the impact of papers produced by Caroline Pirritt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caroline Pirritt. The network helps show where Caroline Pirritt may publish in the future.
Co-authorship network
The 22 scholars most cited alongside Caroline Pirritt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 240 | |
| 2 | 2008 | 2 | |
| 3 | 2007 | 118 | |
| 4 | Preclinical characterization of OSI-906: A novel IGF-1R kinase inhibitor in clinical trials | 2007 | 4 |
| 5 | In vivo evaluation of OSI-906, a novel small molecule kinase inhibitor of the insulin-like growth factor-1 receptor (IGF-1R) | 2007 | 5 |
About Caroline Pirritt
Caroline Pirritt is a scholar working on Endocrinology, Diabetes and Metabolism, Cancer Research and Oncology, having authored 5 papers that have together received 369 indexed citations. Recurring topics across this work include Growth Hormone and Insulin-like Growth Factors (4 papers), Cancer, Hypoxia, and Metabolism (3 papers), Metabolism, Diabetes, and Cancer (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Cancer-related Molecular Pathways (1 paper), Cancer Treatment and Pharmacology (1 paper), Lung Cancer Treatments and Mutations (1 paper) and Lung Cancer Research Studies (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (180 citations), Cancer Research (92 citations) and Molecular Biology (248 citations). Frequent co-authors include Mark J. Mulvihill, Maryland Rosenfeld-Franklin, Elizabeth Buck, Qunsheng Ji, Neil W. Gibson, Andrew Cooke, Lee D. Arnold, Matthew O’Connor, Darla Landfair and Yan Yao. Their work appears in journals such as Journal of Clinical Oncology, Molecular Cancer Therapeutics and Future Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.